J&J earnings rise on strong consumer, pharma sales
Johnson & Johnson said its overall earnings increased 9.5% fueled by strong sales from its consumer products division and rising pharmaceutical sales.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.